Ganesh Raghu mainly focuses on Idiopathic pulmonary fibrosis, Internal medicine, Surgery, Pulmonary fibrosis and Intensive care medicine. His biological study spans a wide range of topics, including Physical therapy, Intensive care and FEV1/FVC ratio. The various areas that Ganesh Raghu examines in his Internal medicine study include Gastroenterology and Placebo.
His Surgery research focuses on Lung and how it relates to Mortality rate, Health statistics, Rheumatoid arthritis and Bronchitis. Ganesh Raghu has researched Pulmonary fibrosis in several fields, including Respiratory disease, Molecular biology, Telomerase, Telomere and Etiology. His Intensive care medicine research integrates issues from Guideline and MEDLINE.
His main research concerns Idiopathic pulmonary fibrosis, Internal medicine, Interstitial lung disease, Pathology and Gastroenterology. His Idiopathic pulmonary fibrosis research includes elements of Pulmonary fibrosis, Clinical trial, Vital capacity and Intensive care medicine. His Intensive care medicine research is multidisciplinary, incorporating elements of Lung transplantation, MEDLINE, Guideline, Disease and Physical therapy.
His Internal medicine research includes themes of Placebo and Surgery. The study incorporates disciplines such as Subclinical infection, Hypersensitivity pneumonitis and Lung biopsy in addition to Interstitial lung disease. His work carried out in the field of Pathology brings together such families of science as Bronchoalveolar lavage, Lung injury and Idiopathic interstitial pneumonia.
The scientist’s investigation covers issues in Internal medicine, Idiopathic pulmonary fibrosis, Interstitial lung disease, Nintedanib and In patient. Ganesh Raghu combines subjects such as Gastroenterology, Placebo and Cardiology with his study of Internal medicine. His study explores the link between Placebo and topics such as Tolerability that cross with problems in Exacerbation.
Ganesh Raghu interconnects Vital capacity, Clinical trial, Pulmonologists, Intensive care medicine and Diffusing capacity in the investigation of issues within Idiopathic pulmonary fibrosis. His studies deal with areas such as Guideline and Disease as well as Intensive care medicine. His Interstitial lung disease research is multidisciplinary, relying on both Subclinical infection, Radiology, Lung biopsy and Hypersensitivity pneumonitis.
His primary scientific interests are in Idiopathic pulmonary fibrosis, Internal medicine, Interstitial lung disease, FEV1/FVC ratio and Lung biopsy. His research in Idiopathic pulmonary fibrosis intersects with topics in Vital capacity, Gene expression, Clinical trial, Exacerbation and Respiratory system. His research links Gastroenterology with Internal medicine.
His research on Interstitial lung disease also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez.
American Journal of Respiratory and Critical Care Medicine (2011)
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2002)
Idiopathic pulmonary fibrosis : Diagnosis and treatment. International consensus statement
Jr King;U. Costabel;J. F. Cordier;G. A. DoPico.
American Journal of Respiratory and Critical Care Medicine (2000)
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma.
The New England Journal of Medicine (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King.
American Journal of Respiratory and Critical Care Medicine (2013)
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu;Martine Remy-Jardin;Jeffrey L. Myers;Luca Richeldi.
American Journal of Respiratory and Critical Care Medicine (2018)
Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
Ganesh Raghu;Kevin J Anstrom;Talmadge E King;Joseph A Lasky.
The New England Journal of Medicine (2012)
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Ganesh Raghu;Derek Weycker;John Edelsberg;Williamson Z. Bradford.
American Journal of Respiratory and Critical Care Medicine (2006)
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Harold R. Collard;Bethany B. Moore;Kevin R. Flaherty;Kevin K. Brown.
American Journal of Respiratory and Critical Care Medicine (2007)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu;Bram Rochwerg;Yuan Zhang;Carlos A. Cuello Garcia.
American Journal of Respiratory and Critical Care Medicine (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: